Key result
ACC/AHA and ESC/EACTS valvular disease guidelines diverge notably on asymptomatic severe AS and secondary regurgitation.
Its licence doesn't allow us to show a copy here.
Why the study?
Clinical practice guidelines for valvular heart disease have important differences that may impact management and require clarification and future research.
This review highlights the consistencies and discrepancies between the ACC/AHA and ESC/EACTS guidelines for valvular heart disease management, identifying gaps for future research.
Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.
No takes yet. Share an insight, caveat, or question.
Coisne et al. (2023) conducted a review in Valvular Heart Disease. ACC/AHA and ESC/EACTS Guidelines was evaluated. The ACC/AHA and ESC/EACTS guidelines for the management of valvular heart disease are generally concordant, but present notable differences in recommendations for asymptomatic severe aortic stenosis, secondary mitral regurgitation, and tricuspid regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Valvular heart diseaseMore from Journal of the American College of Cardiology